Crescent Capital BDC, Inc. (CCAP) Price Target Analysis
Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Current Price
$13.75
Price Target
$14.00
Target Range
$14.00 — $14.00
Analyst Rating
Buy
Forward P/E8.3x
Trailing P/E7.6x
Forward PEG—
Implied Growth-99.9%
Median Target$14.00
Analyst Spread0.0%
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Bear Case
$14
+1.8%
Consensus
$14
+1.8%
Bull Case
$14
+1.8%
Valuation Model TargetsConfidence: 32/100
Bear$9
Base$22
Bull$62
CCAP Price Target Analysis
Updated May 7, 2026As of May 7, 2026, Crescent Capital BDC, Inc. (CCAP) has a Wall Street consensus price target of $14.00, based on estimates from 5 covering analysts. With the stock currently trading at $13.75, this represents a potential upside of +1.8%. The company has a market capitalization of $508M.
Analyst price targets range from a low of $14.00 to a high of $14.00, representing a 0% spread in expectations. The median target of $14.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 4 analysts rating the stock as a Buy or Strong Buy,1 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, CCAP trades at a trailing P/E of 7.6x and forward P/E of 8.3x. Analysts expect EPS to grow -99.9% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $21.93, with bear and bull scenarios of $8.78 and $61.77 respectively. Model confidence stands at 32/100, suggesting limited visibility into future performance.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Financial Services stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside+21.3%
Avg Forward P/E8.3x
Peers with Coverage10 / 10
| Company | Market Cap | Price | Target | Upside | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 ARCCAres Capital Corporation | $13.8B | $19.16 | $21.88 | +14.2% | Buy | 10.0x | 32 |
 GBDCGolub Capital BDC, Inc. | $3.5B | $13.31 | $14.33 | +7.7% | Buy | 9.3x | 11 |
 MFICMidCap Financial Investment Corporation | $1.1B | $12.07 | $11.00 | -8.9% | Hold | 8.9x | 14 |
 TPVGTriplePoint Venture Growth BDC Corp. | $226M | $5.57 | $8.95 | +60.7% | Hold | 6.0x | 12 |
 PFLTPennantPark Floating Rate Capital Ltd. | $914M | $9.21 | $10.50 | +14.0% | Buy | 8.2x | 11 |
 CGBDCarlyle Secured Lending, Inc. | $866M | $11.88 | $15.00 | +26.3% | Hold | 8.2x | 7 |
 FSKFS KKR Capital Corp. | $3.2B | $11.42 | $16.50 | +44.5% | Hold | 6.7x | 13 |
 OBDCBlue Owl Capital Corporation | $5.8B | $11.76 | $14.50 | +23.3% | Buy | 8.6x | 13 |
 HTGCHercules Capital, Inc. | $3.0B | $16.44 | $18.92 | +15.1% | Buy | 8.4x | 31 |
 SLRCSLR Investment Corp. | $761M | $13.95 | $16.25 | +16.5% | Buy | 8.7x | 15 |
Upside Potential Comparison
TPVGFSKCGBDOBDCSLRCHTGCARCCPFLTSee CCAP's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CCAP Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CCAP vs BRK-A
Side-by-side business, growth, and profitability comparison vs Berkshire Hathaway Inc..
Start ComparisonCCAP — Frequently Asked Questions
Quick answers to the most common questions about buying CCAP stock.
What is the CCAP stock price target for 2026?
The consensus price target for CCAP is $14, close to the current price of $13.75 (1.8% implied move). Based on 5 analyst estimates, the stock appears fairly valued near current levels.
Is CCAP a buy, sell, or hold?
CCAP has a consensus rating of "Buy" based on 5 Wall Street analysts. The rating breakdown is predominantly bullish, with 4 Buy/Strong Buy ratings. The consensus 12-month price target of $14 implies 1.8% upside from current levels.
Is CCAP stock overvalued or undervalued?
With a forward P/E of 8.3359x, CCAP trades at a relatively low valuation. The consensus target of $14 implies 1.8% appreciation, suggesting the market may be pricing in risks.
How high can CCAP stock go?
The most bullish Wall Street analyst has a price target of $14 for CCAP, while the most conservative target is $14. The consensus of $14 represents the median expectation. Our quantitative valuation model projects a bull case target of $62 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
How many analysts cover CCAP stock?
CCAP is moderately covered, with 5 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 4 have Buy ratings, 1 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the CCAP stock forecast?
The 12-month CCAP stock forecast based on 5 Wall Street analysts shows a consensus price target of $14, with estimates ranging from $14 (bear case) to $14 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $22, with bear/bull scenarios of $9/$62.
What is CCAP's fair value based on fundamentals?
Our quantitative valuation model calculates CCAP's fair value at $22 (base case), with a bear case of $9 and bull case of $62. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 32/100.
What is CCAP's forward P/E ratio?
CCAP trades at a forward P/E ratio of 8.3x based on next-twelve-months earnings estimates compared to a trailing P/E of 7.6x. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy CCAP stock?
CCAP appears fairly valued according to analysts, with a "Buy" rating and minimal upside to the $14 target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do CCAP price targets vary so much?
CCAP analyst price targets range from $14 to $14, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $14 consensus represents the middle ground. Our model's $9-$62 range provides an independent fundamental perspective.